---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-24-045113"
form_type: "8-K"
ticker: "AHCO"
cik: "0001725255"
company_name: "AdaptHealth Corp."
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:25:03.913480+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# AdaptHealth Q3 net income $22.9M, revenue $805.9M; raises free cash flow guidance

## Summary
- Net income attributable to AdaptHealth of $22.9M vs net loss of $454.1M in Q3 2023.
- Revenue $805.9M, up 0.2% YoY; Adjusted EBITDA $164.3M, up 1.9%.
- FY 2024 guidance updated: revenue $3.22-3.26B (down), adjusted EBITDA $655-675M (narrowed), free cash flow $175-195M (up from $160-180M).
- Year-to-date free cash flow $162.7M, more than double prior year's $76.6M.
- Completed sale of certain custom rehab assets during the quarter.

## SEC filing metadata
- accession: 0001628280-24-045113
- form_type: 8-K
- ticker: AHCO
- cik: 0001725255
- company_name: AdaptHealth Corp.
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1725255/000162828024045113/0001628280-24-045113-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1725255/000162828024045113/ahco-20241105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-24-045113
- JSON: https://secwatch.observer/filing/0001628280-24-045113.json
- Plain text: https://secwatch.observer/filing/0001628280-24-045113.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.